NCT01954277

Brief Summary

The purpose of this study is to determine whether electroacupuncture is effective in the treatment of chronic tension-type headache, measured by Headache Impact Test, Visual Analogue Scale and biomarkers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Oct 2010

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2013

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 1, 2013

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 18, 2013

Status Verified

September 1, 2013

Enrollment Period

3 years

First QC Date

September 15, 2013

Last Update Submit

November 15, 2013

Conditions

Keywords

Chronic Tension-Type HeadacheElectroacupunctureHeadache ImpactBDNFTNF

Outcome Measures

Primary Outcomes (1)

  • Pain Visual Analogue Scale (VAS)

    The intensity of pain was measured by a 10 cm VAS. The scores range from no pain (zero) to the worst possible pain (10 cm).

    An expected average of 3 months. (At baseline and at the end of each intervention period).

Secondary Outcomes (1)

  • Headache Impact Test (HIT-6)

    An expected average of 3 months. (At baseline and at the end of each intervention period).

Other Outcomes (1)

  • Biomarkers (BDNF nd TNF)

    An expected average of 3 months. (At baseline and at the end of each intervention period).

Study Arms (2)

Electroacupuncture

EXPERIMENTAL

All patients will receive 10 electroacupuncture sessions.

Device: Electroacupuncture

Placebo Sham

SHAM COMPARATOR

All patients will receive 10 placebo sham sessions.

Device: Placebo Sham

Interventions

Eletroacupuncture performed using acupuncture needles.

Also known as: Electrical acupuncture
Electroacupuncture

Placebo Sham is performed using electrodes, without electrical stimulation. Lights and sounds were identical to active treatment.

Also known as: Placebo, Sham
Placebo Sham

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women,
  • Aged between 18 and 60 years old,
  • Providing informed consent to participate in the study,
  • Literate,
  • Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society.

You may not qualify if:

  • Psychiatric or neurologic disorder that unable patient to consent and follow study protocol,
  • De-compensated systemic disease,
  • Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis),
  • HIV.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Clinicas e Porto Alegre (HCPA)

Porto Alegre, Rio Grande do Sul, 90035-003, Brazil

Location

MeSH Terms

Interventions

Electroacupuncture

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Officials

  • Wolnei Caumo, MD, PhD

    Hospital de Clinicas de Porto Alegre

    STUDY CHAIR
  • Mônica Chassot

    Federal University of Health Science of Porto Alegre

    PRINCIPAL INVESTIGATOR
  • Francislea C. Sehn

    Federal University of Health Science of Porto Alegre

    PRINCIPAL INVESTIGATOR
  • Rafael Vercelino

    Federal University of Health Science of Porto Alegre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Professor and coordinator of Pain & Neuromodulation Lab

Study Record Dates

First Submitted

September 15, 2013

First Posted

October 1, 2013

Study Start

October 1, 2010

Primary Completion

October 1, 2013

Study Completion

November 1, 2013

Last Updated

November 18, 2013

Record last verified: 2013-09

Locations